Inhibition of tumor PD-L1 expression can reduce lung metastasis, providing a therapeutic strategy for advanced CRC patients by blocking the CSF1-CSF1R signaling pathway [72]. This evidence concerns the gene CSF1 and colorectal carcinoma.